SCHEMBL5277014

SCHEMBL5277014

Cc1cc(C2CCN(C(=O)OCc3ccccc3)CC2)c(=O)[nH]n1.Cl[Cu]Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.49
▸ NPC1 O15118 2/20 0.49
▸ RAB9A P51151 2/20 0.49
▸ TRPC3 Q13507 2/20 0.49
▸ TRPC7 Q9HCX4 2/20 0.49
▸ GRIN2B Q13224 8/20 0.48
▸ USP30 Q70CQ3 1/20 0.48
▸ CYP2C19 P33261 1/20 0.47
▸ JAK2 O60674 3/20 0.47
▸ JAK1 P23458 3/20 0.47
▸ TYK2 P29597 2/20 0.47
▸ JAK3 P52333 2/20 0.47
▸ CYP2D6 P10635 2/20 0.46
▸ CYP2C9 P11712 2/20 0.46
▸ HTT P42858 1/20 0.44
▸ CYP3A4 P08684 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2523964 0.96 SMN1; SMN2 (0.53) SMN1; SMN2NPC1RAB9ATRPC3TRPC7
SCHEMBL2524272 0.85 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9ATRPC3TRPC7
SCHEMBL2527780 0.84 SMN1; SMN2 (0.53) SMN1; SMN2NPC1RAB9ATRPC3TRPC7
SCHEMBL2527184 0.81 SMN1; SMN2 (0.57) SMN1; SMN2NPC1RAB9ATRPC3TRPC7
SCHEMBL25427148 0.76 TRPC3 (0.50) SMN1; SMN2NPC1RAB9ATRPC3TRPC7
SCHEMBL31659003 0.76 TRPC3 (0.50) SMN1; SMN2NPC1RAB9ATRPC3TRPC7
SCHEMBL2709584 0.74 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9AGRIN2BUSP30
SCHEMBL20135557 0.74 TRPC3 (0.53) SMN1; SMN2NPC1RAB9ATRPC3TRPC7
SCHEMBL25291831 0.73 SMN1; SMN2 (0.57) SMN1; SMN2NPC1RAB9AGRIN2BUSP30
SCHEMBL6646235 0.72 TNKS (0.53) SMN1; SMN2NPC1RAB9ATRPC3TRPC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1802637-A1 CGRP RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2007-07-04 — — EP disclosed
WO-2006044504-A1 CGRP RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 2006-04-27 — — WO disclosed
Send feedback